Pricing Sheet Templalte.xlsx
XLSX spreadsheet 22 KB Posted
- Solicitation number
- 15DDHQ25Q00000010
About this file
This is a Pricing Sheet Template for a Drug Enforcement Administration (DEA) contract focused on evaluating the abuse potential of various substances through in vivo pharmacological studies. The template covers five ordering periods, each with identical line items for different scientific assays including Locomotor Activity Assay, Drug Discrimination Assays, Cannabinoid Tetrad Assay, and associated incidental costs and drug expenses. Each ordering period allows for 10 instances of locomotor activity assays, 3 instances of drug discrimination maintenance, 10 instances of drug discrimination testing, 10 Cannabinoid Tetrad Assays, and associated incidental costs. The first ordering period specifically targets synthetic opioids, while subsequent periods focus on hallucinogenic substances. The pricing sheet is for Solicitation Number 15DDHQ25Q00000010, which involves investigational study results and methodology documentation for abuse potential evaluations of various drug categories.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 15DDHQ25Q00000010 Amendment 0001 03192025.pdf | ||
| RFQ 15DDHQ25Q00000010.pdf | ||
| PRICING SHEET TEMPLATE - Attachment 1.xlsx | XLSX spreadsheet | |
| Sample BPA Call Order - Attachment 2.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Summary
| PERIOD | Total Cost Per Ordering Period |
| ORDERING PERIOD 1 | $ - 0 |
| ORDERING PERIOD 2 | $ - 0 |
| ORDERING PERIOD 3 | $ - 0 |
| ORDERING PERIOD 4 | $ - 0 |
| ORDERING PERIOD 5 | $ - 0 |
| Total Cost | $ - 0 |
ORDERING PERIOD 1
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Synthetic Opioids and Other Depressants Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | |||||
| ORDERING PERIOD 1 | ||||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price | |
| 0001 | Locomotor Activity Assay Cost | 10 | EA | $ - 0 | ||
| 0002 | Locomotor Activity Assay Incidental Cost | 10 | EA | $ - 0 | ||
| 0003 | Drug Discrimination (monthly maintenance of training drug) Assay Cost | 3 | EA | $ - 0 | ||
| 0004 | Drug Discrimination (training drug) Incidental Cost | 3 | EA | $ - 0 | ||
| 0005 | Drug Discrimination of test drug Assay Cost | 10 | EA | $ - 0 | ||
| 0006 | Drug Discrimination of test drug Incidental Cost | 10 | EA | $ - 0 | ||
| 0007 | Cannabinoid Tetrad Assay | 10 | EA | $ - 0 | ||
| 0008 | Cannabinoid Tetrad Assay incidental cost | 10 | EA | $ - 0 | ||
| 0009 | Drug Cost Not to Exceed | 10 | EA | $ - 0 | ||
| TOTAL COST ($) | $ - 0 | |||||
| 1 TOTAL |
ORDERING PERIOD 2
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 2 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 1001 | Locomotor Activity Assay Cost | 10 | EA | $ - 0 | |
| 1002 | Locomotor Activity Assay Incidental Cost | 10 | EA | $ - 0 | |
| 1003 | Drug Discrimination (monthly maintenance of training drug) Assay Cost | 3 | EA | $ - 0 | |
| 1004 | Drug Discrimination (training drug) Incidental Cost | 3 | EA | $ - 0 | |
| 1005 | Drug Discrimination of test drug Assay Cost | 10 | EA | $ - 0 | |
| 1006 | Drug Discrimination of test drug Incidental Cost | 10 | EA | $ - 0 | |
| 1007 | Cannabinoid Tetrad Assay | 10 | EA | $ - 0 | |
| 1008 | Cannabinoid Tetrad Assay incidental cost | 10 | EA | $ - 0 | |
| 1009 | Drug Cost Not to Exceed | 10 | EA | $ - 0 | |
| TOTAL COST ($) | $ - 0 |
ORDERING PERIOD 3
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 3 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 2001 | Locomotor Activity Assay Cost | 10 | EA | $ - 0 | |
| 2002 | Locomotor Activity Assay Incidental Cost | 10 | EA | $ - 0 | |
| 2003 | Drug Discrimination (monthly maintenance of training drug) Assay Cost | 3 | EA | $ - 0 | |
| 2004 | Drug Discrimination (training drug) Incidental Cost | 3 | EA | $ - 0 | |
| 2005 | Drug Discrimination of test drug Assay Cost | 10 | EA | $ - 0 | |
| 2006 | Drug Discrimination of test drug Incidental Cost | 10 | EA | $ - 0 | |
| 2007 | Cannabinoid Tetrad Assay | 10 | EA | $ - 0 | |
| 2008 | Cannabinoid Tetrad Assay incidental cost | 10 | EA | $ - 0 | |
| 2009 | Drug Cost Not to Exceed | 10 | EA | $ - 0 | |
| TOTAL COST ($) | $ - 0 |
ORDERING PERIOD 4
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 4 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 3001 | Locomotor Activity Assay Cost | 10 | EA | $ - 0 | |
| 3002 | Locomotor Activity Assay Incidental Cost | 10 | EA | $ - 0 | |
| 3003 | Drug Discrimination (monthly maintenance of training drug) Assay Cost | 3 | EA | $ - 0 | |
| 3004 | Drug Discrimination (training drug) Incidental Cost | 3 | EA | $ - 0 | |
| 3005 | Drug Discrimination of test drug Assay Cost | 10 | EA | $ - 0 | |
| 3006 | Drug Discrimination of test drug Incidental Cost | 10 | EA | $ - 0 | |
| 3007 | Cannabinoid Tetrad Assay | 10 | EA | $ - 0 | |
| 3008 | Cannabinoid Tetrad Assay incidental cost | 10 | EA | $ - 0 | |
| 3009 | Drug Cost Not to Exceed | 10 | EA | $ - 0 | |
| TOTAL COST ($) | $ - 0 |
ORDERING PERIOD 5
| PRICING SHEET TEMPLATE: ATTACHMENT 1 | |
| Title: | Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies |
| Agency: | Drug Enforcement Administration | ||||
| ORDERING PERIOD 5 | |||||
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 4001 | Locomotor Activity Assay Cost | 10 | EA | $ - 0 | |
| 4002 | Locomotor Activity Assay Incidental Cost | 10 | EA | $ - 0 | |
| 4003 | Drug Discrimination (monthly maintenance of training drug) Assay Cost | 3 | EA | $ - 0 | |
| 4004 | Drug Discrimination (training drug) Incidental Cost | 3 | EA | $ - 0 | |
| 4005 | Drug Discrimination of test drug Assay Cost | 10 | EA | $ - 0 | |
| 4006 | Drug Discrimination of test drug Incidental Cost | 10 | EA | $ - 0 | |
| 4007 | Cannabinoid Tetrad Assay | 10 | EA | $ - 0 | |
| 4008 | Cannabinoid Tetrad Assay incidental cost | 10 | EA | $ - 0 | |
| 4009 | Drug Cost Not to Exceed | 10 | EA | $ - 0 | |
| TOTAL COST ($) | $ - 0 |
File details come from the government source that posted it. Updated .